U.S. Global Investors (USGI)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-18,800
| Closed | -$1.13M | – | 209 |
|
2019
Q4 | $1.13M | Buy |
+18,800
| New | +$1.13M | 0.51% | 60 |
|
2018
Q2 | – | Sell |
-19,200
| Closed | -$1.01M | – | 164 |
|
2018
Q1 | $1.01M | Buy |
+19,200
| New | +$1.01M | 0.62% | 48 |
|
2017
Q4 | – | Sell |
-12,600
| Closed | -$751K | – | 171 |
|
2017
Q3 | $751K | Sell |
12,600
-1,300
| -9% | -$77.5K | 0.22% | 72 |
|
2017
Q2 | $1.1M | Buy |
+13,900
| New | +$1.1M | 0.38% | 51 |
|